Jun 30, 2016

United Therapeutics Q2 2016 Earnings Report

Total Revenue
$413M
Previous year: $347M
+18.8%
EPS
$4.55
Previous year: $2.55
+78.4%
Gross Profit
$393M
Previous year: $331M
+18.6%
Cash and Equivalents
$838M
Previous year: $254M
+229.2%
Free Cash Flow
$241M
Total Assets
$2.2B
Previous year: $1.74B
+26.8%

United Therapeutics

United Therapeutics